Alibaba Health Information Technology Limited (0241.HK)

3,180 -0,100 (-3,05%) Alla chiusura: 04:08PM HKT

Alibaba Health Information Technology Limited

Tower One
26th Floor Times Square 1 Matheson Street
Causeway Bay
Hong Kong

https://www.alihealth.cn

Settore/i: Healthcare
Settore: Pharmaceutical Retailers
Impiegati a tempo pieno: 1.547

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Shunyan Zhu	Executive Chairman of the Board	5,29M	N/D	1971
Mr. Difan Shen	CEO & Executive Director	3,48M	N/D	1978
Mr. Yanwu Tu	CFO & Executive Director	2,03M	N/D	1979
Ms. Hiu Leong Tsui	Legal Counsel & Joint Company Secretary	N/D	N/D	N/D
Ms. Yin Rui	Chief Marketing Officer	N/D	N/D	N/D
Ms. Zhang Hua	Chief People Officer	N/D	N/D	N/D
Mr. Chun Chung Kwong	Financial Controller	N/D	N/D	N/D
Ms. Deng Yan	Chief Legal Advisor & Joint Company Secretary	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in HKD.

Descrizione

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, adult and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and traditional Chinese medicine through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.

Governance aziendale

L'ISS Governance QualityScore di Alibaba Health Information Technology Limited al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 1; diritti degli azionisti: 10; retribuzione: 10.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.